MedTrace Logo

ECMO for COVID-19 vs Influenza A H1N1 Associated ARDS

NCT05080933 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 308

Last updated 2021-10-18

No results posted yet for this study

Summary

Objective: Veno-venous ECMO has been used as a rescue therapy for patients with severe ARDS associated to influenza A H1N1 and COVID19 viral pneumonia. Little is known about outcome of these patients who required extracorporeal support.

Research question: To compare outcome of patients who required VV ECMO for Covid19 and H1N1 associated ARDS

Conditions

Sponsors & Collaborators

  • University of Turin, Italy

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-22
Primary Completion
2021-02-28
Completion
2021-02-28

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05080933 on ClinicalTrials.gov